ECSP077268A - Polimorfo ii de rapamicina y los usos de los mismos - Google Patents
Polimorfo ii de rapamicina y los usos de los mismosInfo
- Publication number
- ECSP077268A ECSP077268A EC2007007268A ECSP077268A ECSP077268A EC SP077268 A ECSP077268 A EC SP077268A EC 2007007268 A EC2007007268 A EC 2007007268A EC SP077268 A ECSP077268 A EC SP077268A EC SP077268 A ECSP077268 A EC SP077268A
- Authority
- EC
- Ecuador
- Prior art keywords
- rapamycin polymorph
- same
- polymorph
- rapamycin
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente invención provee la Forma II del polimorfo de rapamicina. Esta invención además provee procesos para preparar la Forma II del polimorfo de rapamicina y las composiciones farmacéuticas que incluyen la Forma II del polimorfo de rapamicina
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60309604P | 2004-08-20 | 2004-08-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP077268A true ECSP077268A (es) | 2007-03-29 |
Family
ID=35431373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2007007268A ECSP077268A (es) | 2004-08-20 | 2007-02-21 | Polimorfo ii de rapamicina y los usos de los mismos |
Country Status (22)
Country | Link |
---|---|
US (1) | US7282505B2 (es) |
EP (1) | EP1781671A1 (es) |
JP (1) | JP2008510710A (es) |
KR (1) | KR20070051863A (es) |
CN (1) | CN101039948A (es) |
AR (1) | AR050374A1 (es) |
AU (1) | AU2005277407A1 (es) |
BR (1) | BRPI0514407A (es) |
CA (1) | CA2575887A1 (es) |
CR (1) | CR8929A (es) |
EC (1) | ECSP077268A (es) |
GT (1) | GT200500223A (es) |
IL (1) | IL181170A0 (es) |
MX (1) | MX2007002044A (es) |
NO (1) | NO20071050L (es) |
PA (1) | PA8642501A1 (es) |
PE (1) | PE20060649A1 (es) |
RU (1) | RU2007104518A (es) |
SV (1) | SV2006002201A (es) |
TW (1) | TW200608973A (es) |
WO (1) | WO2006023627A1 (es) |
ZA (1) | ZA200701453B (es) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA82328C2 (uk) | 2002-07-30 | 2008-04-10 | Уайт | Парентеральна композиція на основі гідроксіестеру рапаміцину (варіанти) та спосіб її приготування |
US7349971B2 (en) * | 2004-02-05 | 2008-03-25 | Scenera Technologies, Llc | System for transmitting data utilizing multiple communication applications simultaneously in response to user request without specifying recipient's communication information |
US8551512B2 (en) * | 2004-03-22 | 2013-10-08 | Advanced Cardiovascular Systems, Inc. | Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS |
US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
AU2006213673A1 (en) | 2005-02-09 | 2006-08-17 | Santen Pharmaceutical Co., Ltd. | Formulations for ocular treatment |
JP5528708B2 (ja) | 2006-02-09 | 2014-06-25 | 参天製薬株式会社 | 安定な製剤ならびにそれらを調製および使用する方法 |
KR101520408B1 (ko) | 2006-03-23 | 2015-05-14 | 산텐 세이야꾸 가부시키가이샤 | 혈관 투과성-관련 질환 또는 상태를 위한 제형 및 방법 |
WO2008014222A1 (en) * | 2006-07-25 | 2008-01-31 | Abbott Laboratories | Crystalline forms of rapamycin analogs |
US7812032B2 (en) | 2006-07-25 | 2010-10-12 | Abbott Laboratories | Crystalline forms of rapamycin analogs |
US7820812B2 (en) | 2006-07-25 | 2010-10-26 | Abbott Laboratories | Methods of manufacturing crystalline forms of rapamycin analogs |
US8486926B2 (en) * | 2006-11-17 | 2013-07-16 | Harbor Therapeutics, Inc. | Steroid tetrol solid state forms |
US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414909B2 (en) * | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
US8430055B2 (en) | 2008-08-29 | 2013-04-30 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
JP2008305262A (ja) * | 2007-06-08 | 2008-12-18 | Konica Minolta Business Technologies Inc | サーバ及びシンクライアント環境でのプリンタ紹介方法 |
CN102292078A (zh) | 2008-11-11 | 2011-12-21 | 得克萨斯大学体系董事会 | 哺乳动物雷帕霉素靶蛋白的抑制 |
DE102008060549A1 (de) | 2008-12-04 | 2010-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung |
WO2010084501A1 (en) * | 2009-01-21 | 2010-07-29 | Biocon Limited | A method for determination of sirolimus stability and process for preparing its stable form |
WO2010086863A2 (en) | 2009-02-02 | 2010-08-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Crystalline drug-containing coatings |
WO2011049659A2 (en) * | 2009-08-05 | 2011-04-28 | The Government Of United States, As Represented By The Secretary Of The Army | Novel use and method of rapamycin to treat toxic shock |
US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
MX2014005927A (es) | 2011-11-15 | 2014-06-05 | Novartis Ag | Combinacion de un inhibidor de la fosfoinositida-3-cinasa y un modulador de la senda del transductor y activador de la señal de transcripcion 5 de la cinasa janus 2. |
US20150224190A1 (en) | 2012-07-06 | 2015-08-13 | Mohamed Bentires-Alj | Combination of a phosphoinositide 3-kinase inhibitor and an inhibitor of the IL-8/CXCR interaction |
DK2968281T3 (da) | 2013-03-13 | 2020-11-02 | Univ Texas | Mtor-hæmmere til forebyggelse af vækst af tarmpolyp |
AU2014332080B2 (en) | 2013-10-08 | 2020-02-27 | AI Therapeutics, Inc. | Rapamycin for the treatment of lymphangioleiomyomatosis |
US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
CA2933908C (en) | 2013-12-31 | 2024-01-30 | Rapamycin Holdings, Llc | Oral rapamycin nanoparticle preparations and use |
US10307371B2 (en) | 2014-02-11 | 2019-06-04 | AI Therapeutics, Inc. | Rapamycin for the treatment of lymphangioleiomyomatosis |
MX2016010373A (es) * | 2014-02-11 | 2016-11-30 | Lam Therapeutics Inc | Rapamicina para el tratamiento de linfangioleiomiomatosis. |
HUP1400075A2 (hu) | 2014-02-14 | 2015-08-28 | Druggability Technologies Ip Holdco Jersey Ltd | Sirolimus és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói |
MX2016012712A (es) | 2014-04-04 | 2017-03-31 | Lam Therapeutics Inc | Una formulacion de rapamicina inhalable para tratar afecciones relacionadas con la edad. |
BR112017006842A2 (pt) | 2014-10-07 | 2017-12-12 | Lam Therapeutics Inc | formulação de rapamicina inalável para o tratamento de hipertensão pulmonar |
MA40910A (fr) | 2014-11-07 | 2017-09-12 | Civitas Therapeutics Inc | Poudres de rapamycine pour administration pulmonaire |
CN106478663A (zh) * | 2015-08-26 | 2017-03-08 | 博瑞生物医药(苏州)股份有限公司 | 一种依维莫司的干燥方法 |
ES2871499T3 (es) | 2017-05-15 | 2021-10-29 | Bard Inc C R | Dispositivo médico con recubrimiento de elución de fármaco y capa intermedia |
CN109020995A (zh) * | 2017-06-12 | 2018-12-18 | 鲁南制药集团股份有限公司 | 一种替西罗莫司的晶型物 |
CN113226389B (zh) | 2018-11-14 | 2022-11-08 | 乐通公司 | 在经改性设备表面上具有药物洗脱涂层的医疗设备 |
WO2020209828A1 (en) | 2019-04-08 | 2020-10-15 | Bard Peripheral Vascular, Inc. | Medical device with drug-eluting coating on modified device surface |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA737247B (en) * | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
US3993749A (en) | 1974-04-12 | 1976-11-23 | Ayerst Mckenna And Harrison Ltd. | Rapamycin and process of preparation |
UA41884C2 (uk) * | 1993-11-05 | 2001-10-15 | Амерікан Хоум Продактс Корпорейшн | Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів |
-
2005
- 2005-08-16 AR ARP050103448A patent/AR050374A1/es unknown
- 2005-08-18 AU AU2005277407A patent/AU2005277407A1/en not_active Abandoned
- 2005-08-18 KR KR1020077003941A patent/KR20070051863A/ko not_active Application Discontinuation
- 2005-08-18 SV SV2005002201A patent/SV2006002201A/es unknown
- 2005-08-18 CN CNA2005800353638A patent/CN101039948A/zh active Pending
- 2005-08-18 PE PE2005000957A patent/PE20060649A1/es not_active Application Discontinuation
- 2005-08-18 RU RU2007104518/04A patent/RU2007104518A/ru not_active Application Discontinuation
- 2005-08-18 JP JP2007528004A patent/JP2008510710A/ja not_active Withdrawn
- 2005-08-18 BR BRPI0514407-8A patent/BRPI0514407A/pt not_active IP Right Cessation
- 2005-08-18 US US11/206,472 patent/US7282505B2/en not_active Expired - Fee Related
- 2005-08-18 PA PA20058642501A patent/PA8642501A1/es unknown
- 2005-08-18 GT GT200500223A patent/GT200500223A/es unknown
- 2005-08-18 EP EP05788650A patent/EP1781671A1/en not_active Withdrawn
- 2005-08-18 CA CA002575887A patent/CA2575887A1/en not_active Abandoned
- 2005-08-18 WO PCT/US2005/029364 patent/WO2006023627A1/en active Application Filing
- 2005-08-18 MX MX2007002044A patent/MX2007002044A/es unknown
- 2005-08-18 TW TW094128147A patent/TW200608973A/zh unknown
-
2007
- 2007-02-05 IL IL181170A patent/IL181170A0/en unknown
- 2007-02-15 CR CR8929A patent/CR8929A/es not_active Application Discontinuation
- 2007-02-19 ZA ZA200701453A patent/ZA200701453B/xx unknown
- 2007-02-21 EC EC2007007268A patent/ECSP077268A/es unknown
- 2007-02-23 NO NO20071050A patent/NO20071050L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200608973A (en) | 2006-03-16 |
WO2006023627A8 (en) | 2006-11-30 |
RU2007104518A (ru) | 2008-09-27 |
NO20071050L (no) | 2007-05-15 |
GT200500223A (es) | 2006-03-09 |
WO2006023627A1 (en) | 2006-03-02 |
KR20070051863A (ko) | 2007-05-18 |
BRPI0514407A (pt) | 2008-06-10 |
US20060040971A1 (en) | 2006-02-23 |
PA8642501A1 (es) | 2006-05-16 |
ZA200701453B (en) | 2010-08-25 |
AU2005277407A1 (en) | 2006-03-02 |
IL181170A0 (en) | 2007-07-04 |
US7282505B2 (en) | 2007-10-16 |
PE20060649A1 (es) | 2006-08-10 |
CR8929A (es) | 2007-08-28 |
CA2575887A1 (en) | 2006-03-02 |
EP1781671A1 (en) | 2007-05-09 |
JP2008510710A (ja) | 2008-04-10 |
CN101039948A (zh) | 2007-09-19 |
SV2006002201A (es) | 2006-05-09 |
MX2007002044A (es) | 2007-03-29 |
AR050374A1 (es) | 2006-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP077268A (es) | Polimorfo ii de rapamicina y los usos de los mismos | |
ECSP23004573A (es) | Compuestos y composiciones como inhibidores de cinasa de proteina | |
DOP2006000193A (es) | Compuestos de isoindol-imida y composiciones que los incluye y metodos para su uso | |
ECSP109937A (es) | Pirimidil ciclopentanos como inhibidores de la proteína quinasa akt. | |
DOP2010000320A (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
HN2008000311A (es) | Formas cristalinas de 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida | |
SV2010003469A (es) | Derivados de n- (arilamino) sulfonamidas que incluyen polimorfos como inhibidores de mek asi como las composiciones metodos de uso y de preparacion de los mismos | |
ECSP088749A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
UY30369A1 (es) | Compuestos de pirrolo-pirimidina y sus usos | |
NI201000060A (es) | COMPUESTOS DE TIENOPIRIMIDINA Y PIRAZOLOPIRIMIDINA Y SU USO COMO INHIBIDORES DE mTOR CINASA Y PI3 CINASA. | |
PA8675701A1 (es) | Nuevos derivados del fluoreno, composiciones que los contienen y su utilización | |
CL2011000691A1 (es) | Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias. | |
CR10600A (es) | Ciclopenta (d) pirimidinas hidroxiladas y metoxiladas como inhibidores de akt proteina quinasa | |
UY29601A1 (es) | Arilpirazoles sustituidos | |
CL2012002497A1 (es) | Compuestos derivados de imidazopirimidina,sustituidos, inhibidores de la pde10a; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento o prevencion de trastornos psicoticos, esquizofrenia, enfermedad de parkinson, esclerosis multiple, entre otras. | |
CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
UY28671A1 (es) | Pirido(2.3-d)pirimidina-2,4-diaminas como inhibidores de pde 2 | |
CL2007003100A1 (es) | Compuestos derivados de pirimidina, inhibidores de cisteina proteasa; procesos de preparacion; sales de los compuestos; composicion farmaceutica; y uso para el tratamiento de la malaria. | |
UY29420A1 (es) | Derivados de 2-piridona,composiciones que los contienen, procesos de preparación y aplicación | |
UY29767A1 (es) | Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones | |
PA8667201A1 (es) | Nuevos compuestos farmaceuticos | |
CR9840A (es) | Inhibidores de la pde y combinaciones de los mismos para el tratamiento de trastornos urologicos | |
ECSP11011344A (es) | Nuevos anticuerpos anti-?5?1 y sus usos | |
CR9257A (es) | Polimorfo cci-779 y uso del mismo | |
HN2006029142A (es) | Proceso |